Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Frontera’s Trial for Retinitis Pigmentosa Kicks Off
Frontera Therapeutics has initiated a clinical trial for its gene therapy, FT-002, which is intended for the treatment of X-linked retinitis pigmentosa (XLRP). The first patient has already been given a dose of the gene therapy product. FT-002 is Frontera’s…
FDA Issues Warning Letter to RightEye
The FDA issued a Warning Letter1 on January 31, 2023, to RightEye, LLC, the manufacturer of the RightEye Vision System, for misbranding and adulteration. The RightEye Vision System is a Class II Nystagmograph medical device that has been cleared “recording,…
Regeneron’s EYLEA® Injection Approved for ROP
Regeneron Pharmaceuticals announced that the FDA granted its approval for the use of EYLEA® (aflibercept) Injection as a treatment option for preterm infants suffering from retinopathy of prematurity (ROP). This marks the first time that EYLEA has received approval for…
Endogena Receives FDA Fast Tract Designation for RP
Endogena Therapeutics announced that the US FDA has designated the investigation of its drug EA-2353 for the treatment of retinitis pigmentosa (RP) as a Fast Track development program. This process speeds up the availability of new drugs for serious conditions…
Smart Contact Lens That Diagnoses and Treats Glaucoma
A research team at POSTECH has recently developed a wireless theranostic smart contact lens that combines an IOP sensor and a flexible drug delivery system to control IOP measurement and drug administration in glaucoma. Glaucoma is a common eye disease…
FDA Approves Bausch + Lomb’s Photodynamic Laser
Bausch + Lomb and Modulight Corporation, a biomedical laser company, today announced that the FDA has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) photodynamic therapy (PDT) for the treatment of patients…
Regeneron Wins Patens Case Against Novartis
Regeneron Pharmaceuticals Inc. has won a patent case against Novartis AG in a U.S. court, protecting the company’s drug delivery system for its eye drug Eylea. The US Patent Trial and Appeal Board ruled in favor of Regeneron, stating that…
World’s First And Only Sinusoidal Trifocal Intra Ocular Lens
AcrivaUD Trinova Comes to the Fore with its Four Main Features The world’s first and only sinusoidal trifocal iol Acrivaud trinova used by ophthalmologists in 64 countries across the world to correct cataracts and for refractive lens exchange attracts more…
RCA Acquires Retina Center Northwest
Retina Consultants of America (RCA), a physician management services organization, has added Retina Center Northwest (RCNW) in Washington state,. Financial terms of the deal were not disclosed. With the addition of RCNW, RCA adds to its presence in the Pacific…
High-Tech Contact Lenses May Replace Smart Phones
When Alexander Graham Bell brought us the revolutionary first ever telephone back in 1876, the world was changed forever. Ever since then, telephonic devices have been a mainstay of the modern world; an essential part of our everyday lives. Of…